|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization | |||||
| Net accretion and amortization of investments in marketable securities | |||||
| Loss on disposal of property and equipment | |||||
| Impairment loss | |||||
| Non-cash operating lease expense | |||||
| Amortization of debt discount and issuance costs | |||||
| Loss on extinguishment of debt | |||||
| Warrant issued for services provided | |||||
| Modification expense related to warrants | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract asset | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from maturities of marketable securities | |||||
| Purchases of marketable securities | |||||
| Purchases of property and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from Exercise of warrants issued | |||||
| July 2024 and October 2024 Securities Purchase Agreement | |||||
| Proceeds from issuance of common stock | |||||
| Common Class A | |||||
| July 2024 Securities Purchase Agreement | |||||
| October 2024 Securities Purchase Agreement | |||||
| July 2025 Securities Purchase Agreement | |||||
| Private Placement Securities Purchase Agreement | |||||
| Issuance of common stock under employee stock purchase plan | |||||
| Proceeds from employee stock purchase plan | |||||
| Proceeds from exercise of Series D Warrants | |||||
| Proceeds from exercise of stock options | |||||
| Tax withholdings paid on behalf of employees for net share settlement | |||||
| Proceeds from the issuance of long-term debt and warrants, net of issuance costs | |||||
| Payment of deferred financing costs | |||||
| Repayment of debt | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash equivalents | |||||
| Cash, cash equivalents and restricted cash equivalents, beginning of period | |||||
| Cash, cash equivalents and restricted cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for corporate taxes, net | |||||
| Supplemental disclosures of non-cash investing and financing activities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC | |||||
| Remeasurement of operating lease right-of-use assets | |||||
| Interest income receivable included in prepaid expenses and other current assets | |||||
| Property and equipment purchases included in accounts payable and accrued expenses and other current liabilities | |||||
| Issuance of costs deducted from long-term debt proceeds | |||||
| Deferred financing costs included in prepaid expenses | |||||
| Unrealized loss on short-term investments | |||||
| Conversion of debt principal into common stock (Note 13) | |||||
Loading...